[Asia Economy Reporter Hwang Yoon-joo] SBW Life Science responded on the 21st to an inquiry disclosure request regarding the transfer of management rights by stating, "We are currently conducting due diligence for a strategic investment review by another company (The Lycra Company)."
They added, "We are considering various funding methods, including a third-party allotment paid-in capital increase that may involve a change of the largest shareholder depending on the scale of investment attraction, but nothing has been decided yet."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
